Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUNLUN ENERGY
00135
5
CHINA OILFIELD
02883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 69.02%-16.55M | ---- | -203.64%-53.41M | ---- | 187.79%51.54M | ---- | 39.08%-58.7M | ---- | -65.16%-96.36M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -149.80%-3.67M | ---- | -21.39%-1.47M | ---- | 57.19%-1.21M | ---- | -344.81%-2.83M | ---- | 78.86%-636K |
| Interest expense - adjustment | ---- | -47.24%1.79M | ---- | -39.63%3.38M | ---- | 3.11%5.6M | ---- | -31.49%5.44M | ---- | -13.12%7.93M |
| Impairment and provisions: | ---- | -73.88%2.05M | ---- | -37.83%7.84M | ---- | -53.97%12.61M | ---- | -41.78%27.4M | ---- | 775.76%47.07M |
| -Other impairments and provisions | ---- | -73.88%2.05M | ---- | -37.83%7.84M | ---- | -53.97%12.61M | ---- | -41.78%27.4M | ---- | 775.76%47.07M |
| Revaluation surplus: | ---- | -112.77%-272K | ---- | 13,412.50%2.13M | ---- | -100.12%-16K | ---- | 1,551.57%13.85M | ---- | -322.38%-954K |
| -Other fair value changes | ---- | -112.77%-272K | ---- | 13,412.50%2.13M | ---- | -100.12%-16K | ---- | 1,551.57%13.85M | ---- | -322.38%-954K |
| Asset sale loss (gain): | ---- | -90.91%1K | ---- | --11K | ---- | ---- | ---- | -1,053.01%-15.7M | ---- | -72.41%-1.36M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---15.72M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -90.91%1K | ---- | --11K | ---- | ---- | ---- | 101.47%20K | ---- | -70.89%-1.36M |
| Depreciation and amortization: | ---- | -34.59%7.2M | ---- | -22.06%11.01M | ---- | -26.41%14.13M | ---- | -53.37%19.2M | ---- | 4.49%41.16M |
| -Amortization of intangible assets | ---- | ---- | ---- | ---- | ---- | -36.86%2.79M | ---- | 50.60%4.42M | ---- | 76.49%2.94M |
| Special items | ---- | -201.47%-820K | ---- | -30.77%-272K | ---- | 98.73%-208K | ---- | -1,736.10%-16.38M | ---- | -108.80%-892K |
| Operating profit before the change of operating capital | ---- | 66.62%-10.28M | ---- | -137.34%-30.78M | ---- | 397.27%82.44M | ---- | -587.14%-27.73M | ---- | -273.89%-4.04M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -52.03%-10.69M | ---- | 79.51%-7.03M | ---- | -201.09%-34.34M | ---- | 220.71%33.97M | ---- | 313.40%10.59M |
| Accounts payable increase (decrease) | ---- | 87.34%-19.57M | ---- | -255.71%-154.54M | ---- | 564.40%99.25M | ---- | -87.12%14.94M | ---- | 3,758.74%115.98M |
| Financial assets at fair value (increase)decrease | ---- | -56.62%259K | ---- | -66.08%597K | ---- | -75.30%1.76M | ---- | 224.15%7.13M | ---- | -25.17%-5.74M |
| Special items for working capital changes | ---- | -21.08%152.36M | ---- | 181.52%193.05M | ---- | -151.22%-236.81M | ---- | 17.76%-94.26M | ---- | -529.84%-114.62M |
| Cash from business operations | ---- | 8,521.23%112.08M | ---- | 101.48%1.3M | ---- | -32.94%-87.7M | ---- | -3,126.01%-65.97M | ---- | 107.62%2.18M |
| Other taxs | ---- | ---9.83M | ---- | ---- | ---- | -354.33%-1.59M | ---- | 115.73%624K | ---- | -693.40%-3.97M |
| Interest received - operating | ---- | 242.19%438K | ---- | -91.57%128K | ---- | -43.45%1.52M | ---- | --2.69M | ---- | ---- |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.00%-2K |
| Special items of business | -114.60%-13.51M | ---- | 823.80%92.49M | ---- | 108.08%10.01M | ---- | -410.73%-123.88M | ---- | -306.62%-24.26M | ---- |
| Net cash from operations | -114.60%-13.51M | 7,090.69%102.68M | 823.80%92.49M | 101.63%1.43M | 108.08%10.01M | -40.07%-87.77M | -410.73%-123.88M | -3,402.35%-62.66M | -306.62%-24.26M | 93.85%-1.79M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 535.15%3.14M | ---- | -27.21%495K | ---- | 375.52%680K | ---- | -85.21%143K | ---- | -60.72%967K |
| Decrease in deposits (increase) | ---- | -64,866.67%-7.8M | ---- | -1,100.00%-12K | ---- | 92.86%-1K | ---- | -100.21%-14K | ---- | 550.20%6.75M |
| Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 18.77%5.55M | ---- | 92.30%4.67M |
| Purchase of fixed assets | ---- | -429.51%-7.63M | ---- | 68.74%-1.44M | ---- | -3,555.56%-4.61M | ---- | 97.46%-126K | ---- | 87.05%-4.97M |
| Sale of subsidiaries | ---- | ---- | ---- | ---670K | ---- | ---- | ---- | ---1.17M | ---- | ---- |
| Recovery of cash from investments | ---- | --2.72M | ---- | ---- | ---- | -36.43%3.67M | ---- | -93.08%5.77M | ---- | -54.12%83.38M |
| Cash on investment | ---- | 91.77%-859K | ---- | -185.79%-10.44M | ---- | -69.55%-3.65M | ---- | 97.18%-2.15M | ---- | 60.91%-76.45M |
| Other items in the investment business | 1,331.18%11.65M | -98.90%3K | 90.27%-946K | 104.51%272K | -217.09%-9.72M | -87.79%133K | -124.43%-3.07M | 8.90%1.09M | -21.78%12.55M | --1M |
| Net cash from investment operations | 1,331.18%11.65M | 11.73%-10.41M | 90.27%-946K | -212.21%-11.79M | -217.09%-9.72M | -141.56%-3.78M | -124.43%-3.07M | -40.84%9.09M | -21.78%12.55M | 126.52%15.36M |
| Net cash before financing | -102.03%-1.86M | 990.33%92.27M | 31,467.24%91.55M | 88.68%-10.36M | 100.23%290K | -70.89%-91.54M | -984.44%-126.94M | -494.64%-53.57M | -216.15%-11.71M | 115.60%13.57M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -94.70%75K | ---- | -98.20%1.42M | ---- | --78.49M | ---- | ---- | ---- | ---- |
| Refund | ---- | -123.63%-33.89M | ---- | 44.75%-15.16M | ---- | 46.91%-27.43M | ---- | ---51.67M | ---- | ---- |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -17.47%10.81M |
| Interest paid - financing | ---- | -62.96%-176K | ---- | 54.43%-108K | ---- | -58.00%-237K | ---- | 87.30%-150K | ---- | 89.08%-1.18M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.16M |
| Other items of the financing business | 22.51%-8.62M | ---- | -64.53%-11.13M | ---- | -109.18%-6.76M | -81.25%1.37M | 272.54%73.64M | 231.35%7.29M | -1,726.36%-42.68M | -138.54%-5.55M |
| Net cash from financing operations | 22.51%-8.62M | -110.87%-38.38M | -64.53%-11.13M | -137.87%-18.2M | -109.18%-6.76M | 200.11%48.07M | 272.54%73.64M | -187.90%-48.01M | -1,726.36%-42.68M | -186.35%-16.68M |
| Effect of rate | -113.92%-169K | -283.05%-452K | 48.05%1.21M | 91.88%-118K | 153.63%820K | -474.74%-1.45M | -353.57%-1.53M | 45.32%388K | 111.58%603K | 116.89%267K |
| Net Cash | -113.04%-10.49M | 288.67%53.89M | 1,342.14%80.42M | 34.30%-28.57M | 87.85%-6.47M | 57.20%-43.48M | 2.00%-53.3M | -3,173.67%-101.58M | -802.60%-54.39M | 96.66%-3.1M |
| Begining period cash | 88.44%113.87M | -32.19%60.43M | -32.19%60.43M | -33.52%89.11M | -33.52%89.11M | -43.02%134.04M | -43.38%134.04M | -1.19%235.24M | -0.56%236.74M | -28.40%238.07M |
| Cash at the end | -27.34%103.21M | 88.44%113.87M | 70.22%142.06M | -32.19%60.43M | 5.36%83.46M | -33.52%89.11M | -56.70%79.21M | -43.02%134.04M | -25.66%182.95M | -1.19%235.24M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.